Opportunities for expanding clinical trial enrollment for relapsed and refractory pediatric acute myeloid leukemia in the United States and Canada-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Opportunities for expanding clinical trial enrollment for relapsed and refractory pediatric acute myeloid leukemia in the United States and Canada

Published:2017-05-16 Issue:11 Volume:64 Page:e26632
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Alexander Thomas B.¹²^ORCID,Bhakta Nickhill³,Kolb E. Anders⁴,Rubnitz Jeffrey E.¹

Affiliation:

1. Departments of Oncology, St. Jude Children's Research Hospital; Memphis Tennessee

2. Department of Pediatrics; University of North Carolina; Chapel Hill North Carolina

3. Global Pediatric Medicine, St. Jude Children's Research Hospital; Memphis Tennessee

4. Nemours/Alfred I. duPont Hospital for Children; Wilmington Delaware

Funder

American Lebanese Syrian Associated Charities (ALSAC)

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference10 articles.

1. Collaborative efforts driving progress in pediatric acute myeloid leukemia;Zwaan;J Clin Oncol,2015

2. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A Therapeutic Advances in Childhood Leukemia (TACL) consortium study;Gorman;Pediatr Blood Cancer,2010

3. Improved outcome in pediatric relapsed acute myeloid leukemia: Results of a randomized trial on liposomal daunorubicin by the International BFM Study Group;Kaspers;J Clin Oncol,2013

4. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement;Moher;J Clin Epidemiol,2009

5. Trends in childhood cancer incidence in the U.S. (1992-2004);Linabery;Cancer,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world experience in treating pediatric relapsed/refractory or therapy‐related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium;Pediatric Blood & Cancer;2022-06-21

2. Relapsed acute myeloid leukemia in children and adolescents: current treatment options and future strategies;Leukemia;2022-06-06

3. How I treat pediatric acute myeloid leukemia;Blood;2021-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3